Clinical Trial Update: Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections [Phase 2]

View source ↗

Summary

Phase 2 trial comparing liposomal amphotericin B (Ambisome) to oral voriconazole for prevention of invasive fungal infections in patients with acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2011-05-13